NCT00757016

Brief Summary

To evaluate the pain relief effect of locally injected corticosteroid treatment in women with long-lasting low back pain beginning in pregnancy. We hypothesize that the insertion of the sacrospinous ligament on the ischial spine would be a source of pain and therefore be a target for therapy. Primary outcome measure is reported pain intensity on visual analogue scale and secondary outcome measures number of pain-drawing locations, pain-provoking test results and tests of function.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2004

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2004

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2007

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2007

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

September 19, 2008

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 22, 2008

Completed
Last Updated

September 22, 2008

Status Verified

September 1, 2008

Enrollment Period

3.1 years

First QC Date

September 19, 2008

Last Update Submit

September 19, 2008

Conditions

Keywords

low back painrandomised controlled trialslow release corticosteroidinjection treatment

Outcome Measures

Primary Outcomes (1)

  • Reported pain intensity on visual analogue scale

Secondary Outcomes (1)

  • Physical function

Study Arms (2)

B

PLACEBO COMPARATOR

0.99 ml saline solution 9mg/ml and 0.01 ml fat emulsion will be given once to the sacrospinous ligament insertion.

Drug: Saline solution

A

ACTIVE COMPARATOR

1 ml triamcinolone 20mg/ml (Lederspan), Meda AB, Solna, Sweden) and 1 ml lidocaine hydrochloride 10mg/ml (Xylocain), Astra Zeneca, Södertälje, Sweden)

Drug: Triamcinolone

Interventions

1 ml triamcinolone 20mg/ml will be given once to the insertion of the sacrospinous ligament bilaterally.

Also known as: Lederspan, Meda AB, Solna, Sweden (Triamcinolone)
A

Saline solution

B

Eligibility Criteria

Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • reported ongoing pain in the sacral region with onset during pregnancy with six months to seven years duration after delivery
  • reported pain intensity at present between 30 and 50 mm on a 100 mm horizontal visual analogue scale (VAS)
  • at least one positive pain provocation test out of three and pain elicited on internal palpation at the ischial spine at least unilaterally.

You may not qualify if:

  • on-going low back pain with onset before pregnancy
  • previous back surgery
  • positive straight leg-raising test
  • loss of tendinous reflex in the legs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sundsvall Hospital

Sundsvall, SE-851 86, Sweden

Location

Related Publications (1)

  • Torstensson T, Lindgren A, Kristiansson P. Improved function in women with persistent pregnancy-related pelvic pain after a single corticosteroid injection to the ischiadic spine: a randomized double-blind controlled trial. Physiother Theory Pract. 2013 Jul;29(5):371-8. doi: 10.3109/09593985.2012.734009.

MeSH Terms

Conditions

Back PainLow Back Pain

Interventions

TriamcinoloneSaline Solution

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

PregnadienesPregnanesSteroidsFused-Ring CompoundsPolycyclic CompoundsSteroids, FluorinatedCrystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations

Study Officials

  • Per OJ Kristiansson, M.D., Ph.D.

    County Council of Västernorrland, Sweden

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

September 19, 2008

First Posted

September 22, 2008

Study Start

October 1, 2004

Primary Completion

November 1, 2007

Study Completion

November 1, 2007

Last Updated

September 22, 2008

Record last verified: 2008-09

Locations